A new agreement between the Carl R. Woese Institute for Genomic Biology (IGB) at the University of Illinois at Urbana-Champaign and ZEISS has named the Core Facilities at IGB as an official ZEISS labs@location Partner. The model facility will allow researchers from around the U.S. to test-d ... more
World Finance 100 Award for Carl Zeiss MicroscopyThe Carl Zeiss Microscopy business group is one of the world's 100 financially most successful companies
The Carl Zeiss Microscopy business group has received the World Finance 100 Award for its financial performance in 2011, presented by the British financial magazine World Finance. In fiscal year 2010/11 the Microscopy business group generated revenue totaling EUR 423m. This corresponds to an increase of EUR 26m – or seven percent – over the prior year (EUR 397m). During the reporting period Carl Zeiss Microscopy won an additional market share in almost all markets – both with microscopes for biomedical research and with systems for materials microscopy in industry. The business group achieved particularly strong growth in Latin America, Asia and Europe. The fusion of light and electron microscopy into a single business group started in the fiscal year 2010/11 and makes Carl Zeiss Microscopy the only one-stop provider for the whole portfolio of microscopy.
"We are proud of receiving this award and are delighted that our financial success has earned global recognition. A solid financial foundation enables us to also achieve top performance in the fields of science and technology in the future," says Dr. Ulrich Simon, Executive Vice President of the Microscopy business group.
The British financial magazine World Finance presents this award to the world's 100 financially most successful organizations and individuals every year. Not only financial criteria, but also innovativeness, sustainability and corporate image all play an important role in the jury's decision.
The patent protects a special aphakic intraocular lens (IOL), with which light can be focused on three focal points (near, intermediate and distance vision). The patented trifocal lens reduces the impact of pupil shrinkage and lens eccentricity. VSY Biotechnology BV and its exclusive suppli ... more
Carl Zeiss Meditec AG has brought financial year 2015/16 to a successful close with further growth: Revenue increased by 4.6 percent (adjusted for currency effects: 2.7 percent) to €1,088.4m. Earnings before interest and taxes (EBIT) rose to €154.3m (prior year: €130.6m). The EBIT margin in ... more
- analytica Vietnam on a growth course
- Eurofins acquires environmental testing laboratory business of Ramboll Group ...
- Sartorius acquires software company Umetrics and
- Signaling Continued Investment in China, Bruker Open Beijing Center of Excel ...
- Carl Zeiss Meditec AG wins patent infringement action on trifocal intraocula ...